Literature DB >> 31032191

Metabolic parameters with different thresholds for evaluating tumor recurrence and their correlations with hematological parameters in locally advanced squamous cell cervical carcinoma: an observational 18F-FDG PET/CT study.

Siyao Du1, Hongzan Sun1, Si Gao1, Jun Xin1, Zaiming Lu1.   

Abstract

BACKGROUND: Positron emission tomography (PET) parameters for a combination of the primary tumor and suspicious metastatic lymph nodes (SMLNs) appear to be more potential than those for the primary tumor alone for evaluating tumor recurrence in locally advanced cervical carcinoma (LACC), while the optimal threshold has not been determined. This study investigated the optimal PET parameters and percentage of SUVmax (%SUVmax) thresholds for tumor recurrence evaluation, and the relationship with hematological parameters in patients with LACC treated with concurrent chemoradiotherapy (CCRT).
METHODS: Eighty-nine patients with advanced squamous cell cervical carcinoma (SCCC) scheduled for CCRT underwent pretreatment whole body PET/CT scans. We analyzed PET parameters including maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) of the primary tumor (SUVmax-P, MTV-P, TLG-P) and the combination of the primary tumor and SMLNs (SUVmax-C, MTV-C, TLG-C). The association between PET parameters with different %SUVmax threshold and recurrence-free survival (RFS), and the correlations between PET parameters and hematological parameters including squamous cell carcinoma antigen (SCC-ag), neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and hemoglobin (Hb) were evaluated.
RESULTS: The optimal threshold for evaluating tumor recurrence was 50%SUVmax, and the optimal PET parameter was MTV-C with the 50%SUVmax threshold (MTV-C50%) (c-index =0.752). Multivariate analysis indicated that MTV-C50% [hazard ratio (HR), 1.065; P<0.001], NLR (HR, 1.195; P=0.045) and SMLNs (HR, 2.225; P=0.003) were independent risk factors for RFS. MTV and TLG with most of %SUVmax thresholds had slight-to-moderate correlations with SCC-ag, NLR and PLR. For SCC-ag, MTV-C55% (r=0.500; P<0.001) had the highest correlation coefficient among all parameters. For NLR and PLR, MTV-C50% (r=0.637 and r=0.515, respectively; P<0.001 for both correlations) received the highest correlation coefficient.
CONCLUSIONS: The MTV-C estimated by using a 50%SUVmax threshold, which is related to systemic inflammatory response biomarker (NLR and PLR), can be used as an optimal PET parameter associated with tumor recurrence of LACC.

Entities:  

Keywords:  Cervical squamous cell carcinoma; concurrent chemoradiotherapy (CCRT); positron emission tomography (PET); prognosis

Year:  2019        PMID: 31032191      PMCID: PMC6462570          DOI: 10.21037/qims.2019.02.09

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  29 in total

Review 1.  Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?

Authors:  Louis Harrison; Kimberly Blackwell
Journal:  Oncologist       Date:  2004

2.  Prognostic significance of volume-based metabolic parameters in uterine cervical cancer determined using 18F-fluorodeoxyglucose positron emission tomography.

Authors:  Jang Yoo; Joon Young Choi; Seung Hwan Moon; Duk Soo Bae; Soo Bin Park; Yearn Seong Choe; Kyung-Han Lee; Byung-Tae Kim
Journal:  Int J Gynecol Cancer       Date:  2012-09       Impact factor: 3.437

3.  The correlation between the metabolic tumor volume and hematological parameters in patients with esophageal cancer.

Authors:  Erdem Sürücü; Yusuf Demir; Tarık Şengöz
Journal:  Ann Nucl Med       Date:  2015-08-22       Impact factor: 2.668

4.  The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer.

Authors:  LingLing Pan; JingYi Cheng; Min Zhou; ZhiFeng Yao; YingJian Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-20       Impact factor: 4.553

5.  Do clinical characteristics and metabolic markers detected on positron emission tomography/computerized tomography associate with persistent disease in patients with in-operable cervical cancer?

Authors:  Burcu Esen Akkas; Busra Bedriye Demirel; Aysen Dizman; Gulin Ucmak Vural
Journal:  Ann Nucl Med       Date:  2013-06-21       Impact factor: 2.668

6.  Long-term results and prognostic factors in patients with stage III-IVA squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy from a single institution study.

Authors:  Wataru Kudaka; Yutaka Nagai; Takafumi Toita; Morihiko Inamine; Kozue Asato; Tomoko Nakamoto; Akihiko Wakayama; Takuma Ooyama; Akemi Tokura; Sadayuki Murayama; Yoichi Aoki
Journal:  Int J Clin Oncol       Date:  2012-08-18       Impact factor: 3.402

7.  Anatomical and functional volume concordance between FDG PET, and T2 and diffusion-weighted MRI for cervical cancer: a hybrid PET/MR study.

Authors:  Hongzan Sun; Jun Xin; Shaomin Zhang; Qiyong Guo; Yueyue Lu; Wei Zhai; Long Zhao; Weiai Peng; Baijun Wang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01-25       Impact factor: 9.236

8.  Clinical outcome for chemoradiotherapy in carcinoma of the cervix.

Authors:  S Spensley; R D Hunter; J E Livsey; R Swindell; S E Davidson
Journal:  Clin Oncol (R Coll Radiol)       Date:  2008-12-11       Impact factor: 4.126

9.  Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.

Authors:  Makoto Hirakawa; Yutaka Nagai; Morihiko Inamine; Kazuya Kamiyama; Kazuhiko Ogawa; Takafumi Toita; Sadayuki Murayama; Yoichi Aoki
Journal:  Gynecol Oncol       Date:  2007-10-23       Impact factor: 5.482

10.  Comparison of imaging-based gross tumor volume and pathological volume determined by whole-mount serial sections in primary cervical cancer.

Authors:  Ying Zhang; Jing Hu; Jianping Li; Ning Wang; Weiwei Li; Yongchun Zhou; Junyue Liu; Lichun Wei; Mei Shi; Shengjun Wang; Jing Wang; Xia Li; Wanling Ma
Journal:  Onco Targets Ther       Date:  2013-07-19       Impact factor: 4.147

View more
  5 in total

1.  A predictive model for treatment response in patients with locally advanced esophageal squamous cell carcinoma after concurrent chemoradiotherapy: based on SUVmean and NLR.

Authors:  Chunsheng Wang; Kewei Zhao; Shanliang Hu; Yong Huang; Li Ma; Yipeng Song; Minghuan Li
Journal:  BMC Cancer       Date:  2020-06-10       Impact factor: 4.430

2.  Comparison of Conventional and Radiomic Features between 18F-FBPA PET/CT and PET/MR.

Authors:  Chien-Yi Liao; Jun-Hsuang Jen; Yi-Wei Chen; Chien-Ying Li; Ling-Wei Wang; Ren-Shyan Liu; Wen-Sheng Huang; Chia-Feng Lu
Journal:  Biomolecules       Date:  2021-11-09

3.  Correlation between hematological parameters and PET/CT metabolic parameters in patients with head and neck cancer.

Authors:  Beat Bojaxhiu; Dubravko Sinovcic; Olgun Elicin; Arnoud J Templeton; Mohamed Shelan; Jan Wartenberg; Ian Alberts; Axel Rominger; Daniel M Aebersold; Kathrin Zaugg
Journal:  Radiat Oncol       Date:  2022-08-13       Impact factor: 4.309

4.  The combined role of PET/CT metabolic parameters and inflammatory markers in detecting extensive disease in small cell lung cancer.

Authors:  Yao Hu; Jin Sun; Danming Li; Yangyang Li; Tiannv Li; Yuxiao Hu
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

5.  Relationship of EGFR Mutation to Glucose Metabolic Activity and Asphericity of Metabolic Tumor Volume in Lung Adenocarcinoma.

Authors:  Wonseok Whi; Seunggyun Ha; Sungwoo Bae; Hongyoon Choi; Jin Chul Paeng; Gi Jeong Cheon; Keon Wook Kang; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2020-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.